Selected References:
- Aselton P, et al. 1985. First-trimester drug use and congenital disorders. Obstet Gynecol 65:451-5.
- Check J, et al. 1982. Improvement of cervical mucus factor with guaifenesin. Fertility and Sterility, 37(5): 707-708.
- Briggs GG, et al. 2017. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Cao Y, et al. 2021. Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case-control study. BMJ Open, 11: e053604.
- Check JH, et al. 1982. Improvement of cervical factor with guaifenesin. Fertil Steril 37:707-8.
- Dicpinigattis, et al.. 2003. Effects of guaifenesin on cough reflex and sensitivity. Chest Journal, 126(6): 2178-2181.
- Dude C, et al. 2021. Assessment of the Safety of Common Medications Used During Pregnancy. JAMA, 326(23):2421-2422.
- Heinonen OP, et al. 1977. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group.
- Means G, et al. 2010. Guaifenesin and increased sperm motility: a preliminary case report. Int J Gen Med, 4: 13-14.
- PDR.Net. 2023. Guaifenesin-Drug Summary. PDR.Net Accessed January 31, 2023. https://www.pdr.net/drug-summary/Mucinex-guaifenesin-1275.
- Servey J, et al. 2014, Over-the-Counter Medications in Pregnancy. Am Fam Physician, 90(8):548-55.
- Shaw G, et al. 1998. Maternal illness, including fever, and medication use as risk factors for neural tube defects. Teratology, 57: 1-7.
- Silva R, Lee J, et al. 2007. Is guaifenesin safe during pregnancy? J. Family Practice 56 (8): 669-670.